Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record history shows the study status updated to Completed, replacing the prior Recruiting status, and adds updates to Study Status, Contacts/Locations, and Study Design, with a new Revision: v3.5.4 and recent update dates.
    Difference
    2%
    Check dated 2026-05-16T09:10:31.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page footer’s software/build revision number was updated from v3.5.2 to v3.5.3, reflecting a maintenance/update of the ClinicalTrials.gov site rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:17:50.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:54.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The history shows an addition of Revision: v3.5.0 and a deletion of Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T02:55:10.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.3, was added to the record history and the previous revision, v3.4.2, was removed. This is an administrative update to the page's version history.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:21.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.4.2 and removal of v3.4.1. This is a metadata update to the page with no changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:52.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.